Nothing Special   »   [go: up one dir, main page]

ES456279A1 - A PROCEDURE FOR PREPARING KETOPHOSPHONATE COMPOUNDS. - Google Patents

A PROCEDURE FOR PREPARING KETOPHOSPHONATE COMPOUNDS.

Info

Publication number
ES456279A1
ES456279A1 ES456279A ES456279A ES456279A1 ES 456279 A1 ES456279 A1 ES 456279A1 ES 456279 A ES456279 A ES 456279A ES 456279 A ES456279 A ES 456279A ES 456279 A1 ES456279 A1 ES 456279A1
Authority
ES
Spain
Prior art keywords
ketophosphonate
carbon atoms
preparing
compounds
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES456279A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of ES456279A1 publication Critical patent/ES456279A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/34—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018—Esters of cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

A process for preparing ketophosphonate compounds of the structure: (** formula **) in which A is cycloalkoxy of three to ten carbon atoms, 1-adamantyl, 2-norbornyl, 2- (1,2,3,4 -tetrahydronaphthyl), 2-indanyl or substituted 2-indanyl wherein said substituent is halogen, trifluoromethyl, alcohol of 1 to 4 carbon atoms or alkoxy of 1 to 4 carbon atoms; n is an integer from 0 to 05; characterized by reacting an alcoholic ester (from 1 to 4 carbon atoms). (Machine-translation by Google Translate, not legally binding)
ES456279A 1972-11-08 1977-11-25 A PROCEDURE FOR PREPARING KETOPHOSPHONATE COMPOUNDS. Expired ES456279A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30475072A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
ES456279A1 true ES456279A1 (en) 1978-11-01

Family

ID=23177829

Family Applications (3)

Application Number Title Priority Date Filing Date
ES420386A Expired ES420386A1 (en) 1972-11-08 1973-11-09 16,17,18,19,20-pentanorprostaglandins
ES444398A Expired ES444398A1 (en) 1972-11-08 1976-01-16 16,17,18,19,20-pentanorprostaglandins
ES456279A Expired ES456279A1 (en) 1972-11-08 1977-11-25 A PROCEDURE FOR PREPARING KETOPHOSPHONATE COMPOUNDS.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES420386A Expired ES420386A1 (en) 1972-11-08 1973-11-09 16,17,18,19,20-pentanorprostaglandins
ES444398A Expired ES444398A1 (en) 1972-11-08 1976-01-16 16,17,18,19,20-pentanorprostaglandins

Country Status (20)

Country Link
JP (1) JPS5714347B2 (en)
AT (1) AT345999B (en)
BE (1) BE807046A (en)
CA (1) CA1033727A (en)
CH (1) CH593930A5 (en)
DE (1) DE2355731C3 (en)
DK (1) DK143499C (en)
ES (3) ES420386A1 (en)
FI (1) FI58912C (en)
FR (3) FR2205338B1 (en)
GB (1) GB1456838A (en)
IE (1) IE40043B1 (en)
IL (2) IL50310A (en)
IN (1) IN139265B (en)
NL (1) NL7315307A (en)
NO (2) NO143663C (en)
PH (2) PH13261A (en)
SE (4) SE412229B (en)
SU (2) SU667131A3 (en)
ZA (1) ZA738595B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
JPS5823393B2 (en) * 1974-03-14 1983-05-14 オノヤクヒンコウギヨウ カブシキガイシヤ prostaglandin
US4028396A (en) * 1975-07-02 1977-06-07 American Cyanamid Company 16,16-Spirocycloalkyl prostaglandin derivatives
NZ183136A (en) * 1976-02-11 1978-11-13 Miles Lab Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions
US4074063A (en) * 1976-02-11 1978-02-14 Miles Laboratories, Inc. Bicycloalkyl derivatives of prostaglandins
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
DE2753995A1 (en) * 1977-12-03 1979-06-07 Bayer Ag NEW BICYCLOALKENYL PROSTAGLANDINS AND THE METHOD OF MANUFACTURING THEM
ATE227266T1 (en) * 1997-09-09 2002-11-15 Procter & Gamble AROMATIC C16-C20-SUBSTITUTED TETRAHYDRO-PROSTAGLANDINS AND THEIR USE AS PROSTAGLANDIN F AGONISTS
KR20010023837A (en) * 1997-09-09 2001-03-26 데이비드 엠 모이어 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
AU731153B2 (en) * 1997-09-09 2001-03-22 Duke University Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists
WO2000051980A1 (en) * 1999-03-05 2000-09-08 The Procter & Gamble Company C16 unsaturated fp-selective prostaglandins analogs
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
ATE432910T1 (en) * 2007-11-28 2009-06-15 Bauer Maschinen Gmbh WINDS
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20230097470A1 (en) * 2021-08-23 2023-03-30 Chirogate International Inc. Processes and intermediates for the preparations of carboprost and carboprost tromethamine, and carboprost tromethamine prepared therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4864073A (en) * 1971-04-30 1973-09-05

Also Published As

Publication number Publication date
DK143499B (en) 1981-08-31
FI58912B (en) 1981-01-30
NO144385C (en) 1981-08-19
NO143663C (en) 1981-03-25
JPS5714347B2 (en) 1982-03-24
BE807046A (en) 1974-05-08
GB1456838A (en) 1976-11-24
JPS49133357A (en) 1974-12-21
ES420386A1 (en) 1976-07-01
NO743616L (en) 1974-05-09
AT345999B (en) 1978-10-10
IL43571A (en) 1977-08-31
PH13261A (en) 1980-02-25
SE7701523L (en) 1977-02-10
FR2291200A1 (en) 1976-06-11
SE7612261L (en) 1976-11-03
NL7315307A (en) 1974-05-10
ES444398A1 (en) 1977-12-01
FR2205338A1 (en) 1974-05-31
DE2355731C3 (en) 1981-01-15
IL50310A (en) 1977-08-31
FI58912C (en) 1981-05-11
NO143663B (en) 1980-12-15
AU6230273A (en) 1975-05-08
IL43571A0 (en) 1974-03-14
SU667131A3 (en) 1979-06-05
ZA738595B (en) 1974-09-25
FR2291200B1 (en) 1979-01-05
CA1033727A (en) 1978-06-27
DK143499C (en) 1982-01-11
FR2205338B1 (en) 1978-07-13
PH13320A (en) 1980-03-13
IN139265B (en) 1976-05-29
IE40043B1 (en) 1979-02-28
FR2286147B1 (en) 1978-09-22
SE417957B (en) 1981-04-27
SU704456A3 (en) 1979-12-15
NO144385B (en) 1981-05-11
IE40043L (en) 1974-05-08
DE2355731B2 (en) 1980-04-30
FR2286147A1 (en) 1976-04-23
DE2355731A1 (en) 1974-05-22
CH593930A5 (en) 1977-12-30
SE412229B (en) 1980-02-25
ATA941073A (en) 1978-02-15
SE7612262L (en) 1976-11-03

Similar Documents

Publication Publication Date Title
ES456279A1 (en) A PROCEDURE FOR PREPARING KETOPHOSPHONATE COMPOUNDS.
ES413639A1 (en) Dopamine derivatives
ES413267A1 (en) Indenyl compounds
ES389912A1 (en) Hydroxy ethers having odorant properties
ES378206A1 (en) 2-(imidazolid inylidence-(2)-amino)-5-nitro-thiazoles and salts thereof
ES364980A1 (en) A method for preparing new adamantan derivatives. (Machine-translation by Google Translate, not legally binding)
ES430417A1 (en) N-substituted prostaglandin carboxamides
ES285790A1 (en) Procedure for the production of succinimides (Machine-translation by Google Translate, not legally binding)
ES432465A1 (en) Substituted 4-biphenylyl-butenoic acids esters and amides and pharmaceutical compositions containing them
ES383342A1 (en) P-carbamoylethylphenylsulfonyl derivatives
ES226732A1 (en) A procedure for the preparation of derivatives of difenilalcanos and difenilalcenos (Machine-translation by Google Translate, not legally binding)
ES428624A1 (en) Procedure for the preparation of pyrimidine derivatives. (Machine-translation by Google Translate, not legally binding)
ES437041A1 (en) A procedure for preparing 1-ftalazone derivatives. (Machine-translation by Google Translate, not legally binding)
ES461191A1 (en) New nn**11piperidinyl*alkyl* aryl carboxysamide derivative
ES441003A1 (en) Oxaprostaglandins
ES285360A1 (en) Procedure for the preparation of tricyclic compounds (Machine-translation by Google Translate, not legally binding)
ES457688A1 (en) New procedure for obtaining acid salts from addition of 3-phenyl-5-dietilamino-etil-1,2-4, -oxodiazol. (Machine-translation by Google Translate, not legally binding)
ES384868A1 (en) A procedure for the preparation of pharmacodyamically active derivatives of hydroxyalcohylpiperazine. (Machine-translation by Google Translate, not legally binding)
ES289751A1 (en) Procedure for obtaining small granulates (Machine-translation by Google Translate, not legally binding)
ES329067A1 (en) Procedure for the preparation of heterociclic compounds. (Machine-translation by Google Translate, not legally binding)
ES385679A1 (en) N-arylidene derivatives of erythromycylamine
ES461637A1 (en) A procedure for the preparation of tiazolinil compounds cetobenzimidazoles. (Machine-translation by Google Translate, not legally binding)
ES231820A3 (en) Procedure for the preparation of oxazolidonic derivatives (Machine-translation by Google Translate, not legally binding)
ES320083A1 (en) Procedure for the preparation of derivatives of difenylamine. (Machine-translation by Google Translate, not legally binding)
ES399725A1 (en) Esters of metatyrosine